HAEMODIALYSIS Acid Solution + Bicarbonate Cartirdge

Name ;HAEMODIALYSIS Acid solution + Bicarbonate cartirdge

Available Model ;GAMBRO

Composition The drug includes 1053.381 g NaCl, 32.616 g KCl, 38.588 g CaCl2,17.789g MgCl2, 30.025 ml CH3COOH per pouch.

Indications ;To patients of Haemodialysis.

Applicability;The drug is intended to Haemodialysis of acute and chronic kindey failure, drug poisoning and electrolyte abnormalities.

Administration ;1. Freshly made before used, dissolve a pouch of A into dialysiswater up to 5.0L, after being A, then being indicated inHaemodialysis on the condition of airproof

2. Drymeal being dissloved into solution in propotion with A : B : Water as 1:1.225:32.775. Dosage ;A pouch is enough for one patient to normally dialyze. Side –effects and special precautions ;The drug may result in glycopenia to individual person because short of glucose special precautions: Intravenous Injection of 50 percent 40-60ml glucose, under the guidance of doctors according to patient’s condition.

First, all the raw materials used for medical injection grade high purity raw materials.Salts of heavy metals and heavy metal residues meet and exceed the "Chinese Pharmacopoeia" 2005 edition requirements, long-term dialysis is more secure, and reliable.
Second, all suppliers of raw materials for the GMP certification.
Third, the whole process of dialysis powder production plant in the GMP certification (100,000) were, truly the whole production process from raw materials to cascade environmental quality standards.
Fourth, product testing program to cover the microbial limit from the solute concentration, bacterial endotoxin and particulate detection, all detected targets are consistent with the forthcoming "and related therapeutic hemodialysis concentrate" that dialysis with the dry powder / concentrate the industry standard requirements.
Fifth, no pungent odor.
VI, no acetic acid, to solve some of the patient's intolerance symptoms (such as: itching, control of inflammatory cytokine release.)
Seven kinds of models for name-specific formula.
VIII, bacteria ≤ 100cfu/ml, fungi ≤ 20cfu/ml, Escherichia coli not detected (concentrated liquid).
September, endotoxin ≤ 0.5fu/ml (dialysis fluid).
X. ≥ 10um particulate matter less than 12 particles / ml
≥ 25um particles less than 3 / ml.
XI, formulation more scientific, after years of clinical and scientific experiments, no acid-based powder on the long-term dialysis patients with hemodialysis have increased the effectiveness of nutrition and metabolism than the traditional recipe in the post-dialysis and dialysis patients in the obvious comfort increased.
Second, a part of residual renal function in patients with diuretic effect. Maintain its residual function decline.

For acute and chronic renal failure and hemodialysis patients with drug poisoning
Campbell (Gambro) and Baxter (Baxter) the company's percentage of hemodialysis machine and the dialysis solution mixing ratio although the interpretation of the same, but the formula is different, if not re-regulation, can not cross its dry powder used in hemodialysis.
Calcium concentration: the case under domestic hemodialysis patients, different specifications of calcium dialysate were 1.5MOl / L (or 3.0mEq / L). If you have special to, users can request allocation of low calcium or high calcium dialysis dry.
A dose of the product from (A solution, A pink) and B agent (B solution B powder) composition. Composition of sodium chloride, potassium chloride, calcium chloride, magnesium chloride, acetic acid, citric acid, anhydrous sodium acetate, sodium bicarbonate.
10L composition: Sodium chloride 210.7g, potassium chloride 5.22g, Magnesium 3.56g, Calcium 9.00g, glacial acetic acid 6.31g.
10L composition: Sodium chloride 210.7g, potassium chloride 5.22g, magnesium chloride
3.56g, Calcium 6.43g, glacial acetic acid 6.31g. D761/10L components: Chlorine
Sodium 210.7g, potassium chloride 5.22g, Magnesium 3.56g, calcium chloride
6.43g, glacial acetic acid 6.31g, anhydrous glucose 35.00g.